Dr. John Harper, Senior Medical Scientist at 3M Healthcare, joins Board at Kent Imaging

January 27, 2020. Kent Imaging announced today the addition of Dr. John Harper, Ph.D. to its Board of Directors and welcomes him as an investor in the organization. His addition to the board complements and strengthens its existing directors’ expertise in business, medicine and marketing by adding advanced product strategies and strong industry connections. 

“We are extraordinarily pleased with the addition of Dr. Harper to the Board of Directors and are honored to have him on the team” comments Don Chapman, Founder and Chairman of the Board at Kent Imaging. “He will contribute a wealth of knowledge, strategic insight, medical product development and commercialization experience to the Board.”

Dr. Harper brings over 35 years of research and healthcare industry experience to the table.  During his tenure at LifeCell, Dr. Harper oversaw the development of pivotal scientific and clinical data proving the utility of its regenerative products AlloDerm, Strattice, and GraftJacket.  He also led the introduction of Novadaq and SPY Elite technology to LifeCell for launching into the plastic surgery space. Currently, Dr. Harper is a Senior Medical Scientist at 3M – Medical Solutions Division, providing leadership over the company’s global technology and innovation outreach, as well as product portfolio strategy and execution. Prior to 3M’s recent acquisition of KCI, Dr. Harper led KCI’s Center for Advanced Research and Technology, as well served as Senior Vice President for Global Clinical and Regulatory Affairs.  Most recently as Chief Technology Officer at KCI, Dr. Harper was responsible for early stage innovation and technology development.  Dr. Harper received his Ph.D. in Biomedical Sciences from The University of Texas, M.D. Anderson Cancer Center in Houston and completed post-doctoral fellowships in cancer biochemistry and cell biology at Scripps Clinic in La Jolla, CA and the National Cancer Institute in Bethesda, MD. 

“I am joining Kent’s Board at a time when the need for advancing new technologies in all aspects of surgery and wound care at a cost-effective price point is critical. A number of years back, I took an interest in the imaging technology developed by the company, and am impressed by the progress to date and the direction Kent is taking. I am excited and honored to join the Board and this will provide me with the opportunity to lend my experience and expertise to further enhance growth of the organization” states Dr. Harper.

About Kent Imaging Inc.

Kent Imaging, located in Calgary, Alberta, Canada, is a leading developer of medical technology, who designs, manufactures and markets near infrared imaging technology for wound and surgical care. Kent holds multiple patents in medical technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. For more information about Kent Imaging, visit www.kentimaging.com.

Kent Imaging is honoured in Acquisition International’s (AI) annual Global Excellence Awards as the “Most Innovative Medical Imaging Technology Developer – Canada.”

AI is a UK-based international, monthly, digital business magazine dedicated to delivering vital updates to their corporate readers. The annual Business Excellence Awards winners are hand-picked by AI’s expert judges based on commitment to client service and excellence in their respective sectors. Tissue viability is a key factor in wound healing, and tissue oxygen levels are the best biomarker for predicting this. SnapshotNIR, utilizing near infrared spectroscopy (NIRS) imaging, provides a comprehensive measure of the hemoglobin oxygen saturation of the microvascular bed within the capillaries. The clinically relevant oxygen data captured is then used to assess the wound and impact the treatment choices for better wound management. 

AI-Magazine-Issue-10-2019-Aug19383

Kent Imaging Inc. announces a strategic partnership for sales of SnapshotNIR with MellingMedical

A CVE verified Service-Disabled Veteran-Owned Small Business (SDVOSB). MellingMedical currently serves more than 160 VA Medical Centers, 95 Department of Defence Medical Facilities and Health and Human Services (HHS), including Indian Health Services (IHS) and the Center for Disease Control (CDC). MellingMedical has a well-established presence in the federal purchasing system, making available innovative and cost-effective healthcare solutions, including wound care and diabetes management, to America’s veterans, military and other patients of federal health care facilities.

Kent Imaging Inc. receives US Federal Contractor Verified Vendor status.

Which will allow access for SnapshotNIR within US Federal Government contracts.

Kent Imaging Inc. announces a distribution agreement with LM Medical.

LM Medical will handle the sales distribution of Kent’s imaging technology, SnapshotNIR to wound care clinics and physicians in the St. Louis & Kansas City vicinity.

Kent Imaging Inc. and The Ametus Group (TAG) announce strategic distribution agreement.

TAG will distribute Kent’s imaging technology, SnapshotNIR, to wound care and reconstructive surgical throughout the western United States. SnapshotNIR provides immediate, real-time visualization of tissue oxygen saturation. Oxygen is the best biomarker for tissue viability – knowing this information can support treatment pathway decisions and improve patient outcomes.

MedTech Outlook – Names Kent Imaging as Editor’s Choice in the “Top 10 Medical Imaging Solution Providers for 2018”.

With their break-through near infrared spectroscopy (NIRS) imaging solution SnapshotNIR to assess tissue oxygen saturation, a key indicator of tissue health MedTech Outlook has named Kent Imaging as Editor’s Choice in the “Top 10 Medical Imaging Solutions Providers for 2018.

kent-imaging-editors-choice-l

Kent Imaging Welcomes Clinical Leader, Dr. Adam Landsman, DPM, PhD as Chief Medical Officer

Dr. Landsman’s exceptional background as the Assistant Professor of Surgery at Harvard Medical School will further Kent’s medical device applications.

CALGARY, Nov. 14, 2017 /CNW/ – Kent Imaging Inc., a leading innovator in multispectral oxygenation imaging, today announced that Dr. Adam Landsman, DPM, PhD has joined the company as Chief Medical Officer. Dr. Landsman will serve the team with his clinical background and guide the medical uses of Kent’s technology.

“Kent’s leading edge technology provides physicians and surgeons value based tissue oxygen saturation levels which are key to improved decision making while reducing costs in wound care and surgical healing,” said Dr. Adam Landsman, DPM, PhD, Chief of Division of Podiatric Surgery at the Cambridge Health Alliance (Harvard Medical School). “I have had the opportunity to clinically study and research the benefits of Kent’s device. Seeing the value and understanding the practical need for Kent’s technology in the clinic, I was eager to join the team behind it.”

“I am pleased to have Dr. Landsman, a proven leader with extensive research and clinical expertise, join our team at Kent,” said Pierre Lemire, CEO of Kent Imaging. “This is an exciting time for Kent Imaging as we welcome Dr. Landsman and launch our FDA cleared SnapshotNIR device.”

Dr. Landsman is the Assistant Professor of Surgery at Harvard Medical School. Dr. Landsman holds a PhD and MS in Bioengineering from the University of Pennsylvania, DPM in Podiatric Medicine and Surgery from the Temple University, Pennsylvania College of Podiatric Medicine in which he was the first simultaneous dual degree (DPM/PhD) student in the history of podiatric medical education. Dr. Landsman also holds a BS in Chemical Engineering and English Literature from the University of Virginia.

About Kent Imaging Inc.
Kent Imaging Inc., a leading innovator in multispectral oxygenation imaging, designs, manufactures, and markets imaging technology to improve plastic surgery, colorectal surgery, trauma, wound care, limb salvage, podiatry, burns and cardiac specialties.  The team at Kent Imaging is committed to improving patient outcomes by delivering innovative and practical solutions for the healthcare industry. Kent Imaging holds multiple patents in medical technology and is currently commercializing the breakthrough multispectral imaging solutions that assesses tissue oxygen saturation. The company is headquartered in Calgary, Alberta, Canada, and has locations in Chicago, Los Angeles, Salt Lake City and Seattle.

Kent’s SnapshotNIR is U.S. Food and Drug Administration 510(k) cleared, and Health Canada licensed. The device is available for sale in the United States and Canada. Improving on Kent’s previous KC103, the handheld Kent SnapshotNIR is intended for use by healthcare professionals as a non-invasive tissue oxygenation measurement system that reports oxygen saturation (StO2), relative oxyhemoglobin level (HbO2), and relative deoxyhemoglobin (Hb) level in superficial tissue. Kent’s multispectral imaging technology displays two-dimensional color-coded images of tissue oxygenation of the scanned surface and reports multispectral tissue oxygenation measurements for selected tissue regions. Tissue oxygen saturation measurements provide critical information to help physicians determine at risk tissue and guide treatments to optimize patient outcomes.

Kent Imaging Inc., Vonda-Lee Sharun – Marketing Manager, press@kentimaging.com

Kent Imaging Hires Chief Scientist to Lead Product Research

Kent Imaging announced today the hiring of Dr. Michael Sowa for the role of Chief Scientist. Dr. Sowa brings over 24 years of structured research from his role as Group Leader and Principal Research Officer at the National Research Council of Canada (NRC). During his time at the NRC his was instrumental in their development of ICG angiography which technology lead to the creation of Novadaq and then went on to lead the team that developed the next generation of imaging technology – NIR spectroscopy which formed the basis of Kent’s products. Dr. Sowa will continue to lead the development of medical imaging being developed by Kent Imaging while also be responsible for Kent’s IP strategy.

Kent Imaging Appoints Healthcare Veteran as CEO

Kent Imaging announced today the appointment of seasoned medical imaging executive Pierre Lemire to the role of Chief Executive Officer. Mr. Lemire brings more than 30 years of experience in successfully launching new products to market. Prior to joining Kent Imaging, he co-founded Calgary Scientific and as President, led the company in becoming a global leader in medical imaging. He was also previously Chief Technology Officer for Autodesk, a Silicon Valley company. Kent founder Don Chapman will continue in his role as Executive Chairman assisting Mr. Lemire in launching the company’s new handheld imaging device.